FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113404906> ?p ?o ?g. }

• W2113404906 endingPage "761.e1" @default.
• W2113404906 startingPage "757" @default.
• W2113404906 abstract "Purpose To determine whether baseline drusen load, as measured using spectral-domain optical coherence tomography (SD OCT), is a useful predictor of development of advanced age-related macular degeneration (AMD). Design Retrospective cohort study. Methods setting: Academic clinical practice. study population: All patients with non-neovascular AMD and no retinal pigment epithelial (RPE) atrophy at baseline who were seen between 2007 and 2012 in a single academic retina practice. A minimum of 1 year of follow-up was required. observation: Drusen load (area and volume) was assessed using automated SD OCT software algorithms. main outcome measure: RPE atrophy area, assessed using an automated SD OCT software algorithm, and the development of neovascular AMD. Results Eighty-three patients met the inclusion criteria with a mean age of 80 years and a mean follow-up time of 2.8 years. Repeated-measures analysis of variance showed an association between drusen area (P = .005) and drusen volume (P = .001) and the development of RPE atrophy. We also found an association between drusen area (P = .001) and drusen volume (P = .001) and the development of neovascular AMD. Conclusions Drusen load, as measured using SD OCT, is associated with the development of RPE atrophy and neovascular AMD. SD OCT assessments of drusen load are simple and practical measurements that may be useful in stratifying the risk of developing advanced AMD. These measurements have potential applications in both routine clinical care and clinical trials. To determine whether baseline drusen load, as measured using spectral-domain optical coherence tomography (SD OCT), is a useful predictor of development of advanced age-related macular degeneration (AMD). Retrospective cohort study. setting: Academic clinical practice. study population: All patients with non-neovascular AMD and no retinal pigment epithelial (RPE) atrophy at baseline who were seen between 2007 and 2012 in a single academic retina practice. A minimum of 1 year of follow-up was required. observation: Drusen load (area and volume) was assessed using automated SD OCT software algorithms. main outcome measure: RPE atrophy area, assessed using an automated SD OCT software algorithm, and the development of neovascular AMD. Eighty-three patients met the inclusion criteria with a mean age of 80 years and a mean follow-up time of 2.8 years. Repeated-measures analysis of variance showed an association between drusen area (P = .005) and drusen volume (P = .001) and the development of RPE atrophy. We also found an association between drusen area (P = .001) and drusen volume (P = .001) and the development of neovascular AMD. Drusen load, as measured using SD OCT, is associated with the development of RPE atrophy and neovascular AMD. SD OCT assessments of drusen load are simple and practical measurements that may be useful in stratifying the risk of developing advanced AMD. These measurements have potential applications in both routine clinical care and clinical trials." @default.
• W2113404906 created "2016-06-24" @default.
• W2113404906 creator A5000367082 @default.
• W2113404906 creator A5006220437 @default.
• W2113404906 creator A5018874083 @default.
• W2113404906 creator A5033644887 @default.
• W2113404906 creator A5037748654 @default.
• W2113404906 creator A5043419273 @default.
• W2113404906 creator A5061290075 @default.
• W2113404906 creator A5071707966 @default.
• W2113404906 creator A5084460812 @default.
• W2113404906 date "2014-10-01" @default.
• W2113404906 modified "2023-10-16" @default.
• W2113404906 title "Optical Coherence Tomography–Based Measurement of Drusen Load Predicts Development of Advanced Age-Related Macular Degeneration" @default.
• W2113404906 cites W1971449134 @default.
• W2113404906 cites W1977181227 @default.
• W2113404906 cites W1995708251 @default.
• W2113404906 cites W1996821302 @default.
• W2113404906 cites W2002558743 @default.
• W2113404906 cites W200886222 @default.
• W2113404906 cites W2020344616 @default.
• W2113404906 cites W2027733533 @default.
• W2113404906 cites W2040107814 @default.
• W2113404906 cites W2049823525 @default.
• W2113404906 cites W2050278194 @default.
• W2113404906 cites W2053123102 @default.
• W2113404906 cites W2053517908 @default.
• W2113404906 cites W2058344658 @default.
• W2113404906 cites W2060040689 @default.
• W2113404906 cites W2068742492 @default.
• W2113404906 cites W2081063786 @default.
• W2113404906 cites W2081268901 @default.
• W2113404906 cites W2091742941 @default.
• W2113404906 cites W2093744133 @default.
• W2113404906 cites W2095303849 @default.
• W2113404906 cites W2104421967 @default.
• W2113404906 cites W2112146707 @default.
• W2113404906 cites W2113975222 @default.
• W2113404906 cites W2114455312 @default.
• W2113404906 cites W2115773920 @default.
• W2113404906 cites W2124415048 @default.
• W2113404906 cites W2129572698 @default.
• W2113404906 cites W2160429819 @default.
• W2113404906 cites W2323424471 @default.
• W2113404906 cites W4240524385 @default.
• W2113404906 doi "https://doi.org/10.1016/j.ajo.2014.06.021" @default.
• W2113404906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24983793" @default.
• W2113404906 hasPublicationYear "2014" @default.
• W2113404906 type Work @default.
• W2113404906 sameAs 2113404906 @default.
• W2113404906 citedByCount "45" @default.
• W2113404906 countsByYear W21134049062016 @default.
• W2113404906 countsByYear W21134049062017 @default.
• W2113404906 countsByYear W21134049062018 @default.
• W2113404906 countsByYear W21134049062019 @default.
• W2113404906 countsByYear W21134049062020 @default.
• W2113404906 countsByYear W21134049062021 @default.
• W2113404906 countsByYear W21134049062022 @default.
• W2113404906 countsByYear W21134049062023 @default.
• W2113404906 crossrefType "journal-article" @default.
• W2113404906 hasAuthorship W2113404906A5000367082 @default.
• W2113404906 hasAuthorship W2113404906A5006220437 @default.
• W2113404906 hasAuthorship W2113404906A5018874083 @default.
• W2113404906 hasAuthorship W2113404906A5033644887 @default.
• W2113404906 hasAuthorship W2113404906A5037748654 @default.
• W2113404906 hasAuthorship W2113404906A5043419273 @default.
• W2113404906 hasAuthorship W2113404906A5061290075 @default.
• W2113404906 hasAuthorship W2113404906A5071707966 @default.
• W2113404906 hasAuthorship W2113404906A5084460812 @default.
• W2113404906 hasConcept C118487528 @default.
• W2113404906 hasConcept C126322002 @default.
• W2113404906 hasConcept C2776403814 @default.
• W2113404906 hasConcept C2778818243 @default.
• W2113404906 hasConcept C2779093074 @default.
• W2113404906 hasConcept C2780827179 @default.
• W2113404906 hasConcept C2781172350 @default.
• W2113404906 hasConcept C71924100 @default.
• W2113404906 hasConceptScore W2113404906C118487528 @default.
• W2113404906 hasConceptScore W2113404906C126322002 @default.
• W2113404906 hasConceptScore W2113404906C2776403814 @default.
• W2113404906 hasConceptScore W2113404906C2778818243 @default.
• W2113404906 hasConceptScore W2113404906C2779093074 @default.
• W2113404906 hasConceptScore W2113404906C2780827179 @default.
• W2113404906 hasConceptScore W2113404906C2781172350 @default.
• W2113404906 hasConceptScore W2113404906C71924100 @default.
• W2113404906 hasIssue "4" @default.
• W2113404906 hasLocation W21134049061 @default.
• W2113404906 hasLocation W21134049062 @default.
• W2113404906 hasOpenAccess W2113404906 @default.
• W2113404906 hasPrimaryLocation W21134049061 @default.
• W2113404906 hasRelatedWork W2002437061 @default.
• W2113404906 hasRelatedWork W2017975899 @default.
• W2113404906 hasRelatedWork W2067597951 @default.
• W2113404906 hasRelatedWork W2161462781 @default.
• W2113404906 hasRelatedWork W2336818263 @default.
• W2113404906 hasRelatedWork W2586722160 @default.
• W2113404906 hasRelatedWork W2790585032 @default.
• W2113404906 hasRelatedWork W2914714899 @default.

• next